143 related articles for article (PubMed ID: 34879081)
1. Trends in extent of surgical cytoreduction for patients with ovarian cancer.
Wong DH; Mardock AL; Manrriquez EN; Lai TS; Sanaiha Y; Sinno AK; Benharash P; Cohen JG
PLoS One; 2021; 16(12):e0260255. PubMed ID: 34879081
[TBL] [Abstract][Full Text] [Related]
2. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
[TBL] [Abstract][Full Text] [Related]
3. Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery.
Spencer RJ; Hacker KE; Griggs JJ; Rice LW; Reynolds RK; Uppal S
Obstet Gynecol; 2017 Aug; 130(2):305-314. PubMed ID: 28697111
[TBL] [Abstract][Full Text] [Related]
4. National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery.
Jones NL; Chen L; Chatterjee S; Tergas AI; Burke WM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Int J Gynecol Cancer; 2018 Jan; 28(1):19-25. PubMed ID: 28953134
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
Cham S; Chen L; St Clair CM; Hou JY; Tergas AI; Melamed A; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2019 Jun; 220(6):571.e1-571.e8. PubMed ID: 30771346
[TBL] [Abstract][Full Text] [Related]
6. Association of risk factors with unfavorable outcomes after resection of adult benign intradural spine tumors and the effect of hospital volume on outcomes: an analysis of 18, 297 patients across 774 US hospitals using the National Inpatient Sample (2002-2011).
Kalakoti P; Missios S; Menger R; Kukreja S; Konar S; Nanda A
Neurosurg Focus; 2015 Aug; 39(2):E4. PubMed ID: 26235021
[TBL] [Abstract][Full Text] [Related]
7. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
[TBL] [Abstract][Full Text] [Related]
8. [Technical essentials and safety analysis of "rolling carpet" cytoreduction surgery in stage Ⅲc epithelial ovarian cancer].
Liu H; Shi Y; Zhang GN; Yu J; Xu SQ; Wang DF; Fan Y; Song SQ; Zhou FZ
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):521-528. PubMed ID: 32854476
[No Abstract] [Full Text] [Related]
9. Readmissions after ovarian cancer cytoreduction surgery: The first 30 days and beyond.
Mardock AL; Rudasill SE; Lai TS; Sanaiha Y; Wong DH; Sinno AK; Benharash P; Cohen JG
J Surg Oncol; 2020 Nov; 122(6):1199-1206. PubMed ID: 32700323
[TBL] [Abstract][Full Text] [Related]
10. Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
Greggi S; Falcone F; Carputo R; Raspagliesi F; Scaffa C; Laurelli G; Giorda G; Di Vagno G; Petruzzelli F; Cormio G; Marinaccio M; Pignata S
Gynecol Oncol; 2016 Mar; 140(3):425-9. PubMed ID: 26825616
[TBL] [Abstract][Full Text] [Related]
11. Perioperative morbidity and mortality in octogenarians with ovarian cancer.
Walters CL; Schneider KE; Whitworth JM; Fauci JM; Smith HJ; Barnes MN; Straughn JM
Int J Gynecol Cancer; 2013 Jul; 23(6):1006-9. PubMed ID: 23714708
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
[TBL] [Abstract][Full Text] [Related]
13. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
Ross MS; Burriss ME; Winger DG; Edwards RP; Courtney-Brooks M; Boisen MM
Gynecol Oncol; 2018 Aug; 150(2):306-310. PubMed ID: 29929924
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes.
Matsuo K; Chang EJ; Matsuzaki S; Mandelbaum RS; Matsushima K; Grubbs BH; Klar M; Roman LD; Sood AK; Wright JD
Gynecol Oncol; 2020 Jul; 158(1):59-65. PubMed ID: 32402635
[TBL] [Abstract][Full Text] [Related]
16. Regionalization of care for women with ovarian cancer.
Wright JD; Chen L; Buskwofie A; Tergas AI; St Clair CM; Hou JY; Khoury-Collado F; Ananth CV; Hur C; Neugut AI; Hershman DL
Gynecol Oncol; 2019 Aug; 154(2):394-400. PubMed ID: 31171408
[TBL] [Abstract][Full Text] [Related]
17. Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States.
Charo LM; Jou J; Binder P; Hohmann SF; Saenz C; McHale M; Eskander RN; Plaxe S
Gynecol Oncol; 2020 Dec; 159(3):681-686. PubMed ID: 32977989
[TBL] [Abstract][Full Text] [Related]
18. Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
Nasioudis D; Kahn R; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
Gynecol Oncol; 2019 Aug; 154(2):401-404. PubMed ID: 31160074
[TBL] [Abstract][Full Text] [Related]
19. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
[TBL] [Abstract][Full Text] [Related]
20. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
Bernard L; Boucher J; Helpman L
Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
